New Gene Therapy Could Face Uphill Battle
The potential FDA approval of BioMarin’s gene therapy for hemophilia A would be a major win, but patient uptake could ...
The potential FDA approval of BioMarin’s gene therapy for hemophilia A would be a major win, but patient uptake could ...
Developers of Alzheimer’s drugs have work cut out for them getting the treatments to patients.
June 11, 2023 12:01 am ETListen to article(2 minutes)George Soros, the legendary investor, philanthropist and right-wing target, is handing control ...
Large drug companies need innovation to deal with the drug-pricing law. That is a boon to smaller biotech firms.
Mark Spitznagel and Nassim Nicholas Taleb devised ways to reap huge profits from global chaos—and they expect a lot of ...
The longtime barometer of wood prices and building activity is being replaced with a new lumber-futures contract in an effort ...
ShareListen(2 min)
Distressed-debt specialist Avenue Capital has snapped up part of Caesars’ pandemic-related insurance claim at a steep discount.
Healthcare is finally getting back to normal, which is good news for medical-device makers and hospitals, but not for insurers.
MarketsHeard on the StreetThe decision to get into the business for drugs such as Ozempic makes sense